All Stories

  1. Modeling CIC::DUX4 sarcoma reveals oncogene-mediated MHCI-dependent immune evasion
  2. Estrogen Receptor Regulates Male Satellite Cells in a Female, but Not Male, Environment
  3. Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies
  4. Matrix metalloproteinases are hallmark early biomarkers and therapeutic targets in FSHD
  5. Long-Term Engraftment and Satellite Cell Expansion from Human PSC Teratoma-Derived Myogenic Progenitors
  6. Dux Is Dispensable for Skeletal Muscle Regeneration: A Study Inspired by a “Red Flagged” Publication and Editorial Oversight
  7. When everything is a master regulator, nothing is
  8. Development of p300-targeting degraders with enhanced selectivity and onset of degradation
  9. Estradiol deficiency as a consequence of aging contributes to the depletion of the satellite cell pool in female mice
  10. Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma
  11. Multiparametric identification of putative senescent cells in skeletal muscle via mass cytometry
  12. Cardiac Development Long Non-Coding RNA (CARDEL) Is Activated during Human Heart Development and Contributes to Cardiac Specification and Homeostasis
  13. The homeobox transcription factor DUXBL controls exit from totipotency
  14. Inducing positive inotropy in human iPSC-derived cardiac muscle by gene editing-based activation of the cardiac α-myosin heavy chain
  15. Skin muscle is the initial site of viral replication for arboviral bunyavirus infection
  16. Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein
  17. Genetically prolonged beige fat in male mice confers long-lasting metabolic health
  18. DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells
  19. Cardiac Development Long non-coding RNA (CARDEL) is activated during human heart development and contributes to cardiac specification and homeostasis
  20. Proliferation and Maturation: Janus and the Art of Cardiac Tissue Engineering
  21. Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
  22. Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes
  23. The Satellite Cell Colony Forming Cell Assay as a Tool to Measure Self-Renewal and Differentiation Potential
  24. Not young but still immature: a HIF-1α–mediated maturation checkpoint in regenerating muscle
  25. The fibrotic niche impairs satellite cell function and muscle regeneration in mouse models of Marfan syndrome
  26. The chemokine receptor CXCR4 regulates satellite cell activation, early expansion, and self-renewal, in response to skeletal muscle injury
  27. Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice
  28. Hedgehog signaling activates a mammalian heterochronic gene regulatory network controlling differentiation timing across lineages
  29. Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes
  30. Estradiol deficiency reduces the satellite cell pool by impairing cell cycle progression
  31. Corrigendum: Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
  32. Antiapoptotic Protein FAIM2 is targeted by miR-3202, and DUX4 via TRIM21, leading to cell death and defective myogenesis
  33. Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
  34. Laminin 411 mediates endothelial specification via multiple signaling axes that converge on β-catenin
  35. Exercise Intolerance in Facioscapulohumeral Muscular Dystrophy
  36. Persistent Fibroadipogenic Progenitor Expansion Following Transient DUX4 Expression Provokes a Profibrotic State in a Mouse Model for FSHD
  37. In vitro expanded skeletal myogenic progenitors from pluripotent stem cell-derived teratomas have high engraftment capacity
  38. Editorial overview – Differentiation: the driver of development
  39. Fli1 Promotes Vascular Morphogenesis by Regulating Endothelial Potential of Multipotent Myogenic Progenitors
  40. Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
  41. Preservation of satellite cell number and regenerative potential with age reveals locomotory muscle bias
  42. Resting metabolic rate in adults with facioscapulohumeral muscular dystrophy
  43. B1 lymphocytes develop independently of Notch signaling during mouse embryonic development
  44. Chromatin accessibility profiling identifies evolutionary conserved loci in activated human satellite cells
  45. Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation
  46. Meeting report: the 2020 FSHD International Research Congress
  47. B-1 lymphoid cells develop independently of Notch signaling during mouse embryonic development
  48. Dux facilitates post-implantation development, but is not essential for zygotic genome activation†
  49. Oestradiol affects skeletal muscle mass, strength and satellite cells following repeated injuries
  50. Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
  51. Prospective isolation of human fibroadipogenic progenitors with CD73
  52. Replication of bone-marrow pathophysiology
  53. Transcriptional and cytopathological hallmarks of FSHD in chronic DUX4-expressing mice
  54. DNA aptamers against the DUX4 protein reveal novel therapeutic implications for FSHD
  55. Correction to: Tet3 regulates cellular identity and DNA methylation in neural progenitor cells
  56. Tet3 regulates cellular identity and DNA methylation in neural progenitor cells
  57. A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death
  58. Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies
  59. Estrogen Regulates the Satellite Cell Compartment in Females
  60. Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftment
  61. Crystal Structure of the Double Homeodomain of DUX4 in Complex with DNA
  62. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression
  63. Evolutionarily conserved Tbx5 – Wnt2/2b pathway orchestrates cardiopulmonary development
  64. A Novel Inducible Mouse Model of MLL‐ENL‐driven Mixed‐lineage Acute Leukemia
  65. Comment on structural basis of DUX4/IGH-driven transactivation
  66. A moderate estradiol level enhances neutrophil number and activity in muscle after traumatic injury but strength recovery is accelerated
  67. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells
  68. Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity
  69. Author Correction: Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
  70. ULK1 phosphorylates Ser30 of BECN1 in association with ATG14 to stimulate autophagy induction
  71. Mouse models of two missense mutations in actin-binding domain 1 of dystrophin associated with Duchenne or Becker muscular dystrophy
  72. Notch activation is required for downregulation of HoxA3-dependent endothelial cell phenotype during blood formation
  73. The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain
  74. Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
  75. p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
  76. Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors
  77. A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion
  78. Pax7 remodels the chromatin landscape in skeletal muscle stem cells
  79. Twist of fate for skeletal muscle mesenchymal cells
  80. Cellular Aging Contributes to Failure of Cold-Induced Beige Adipocyte Formation in Old Mice and Humans
  81. Modulating the malignancy of Hox proteins
  82. miR-125bpromotesMLL-AF9–driven murine acute myeloid leukemia involving aVEGFA-mediated non–cell-intrinsic mechanism
  83. Cellular Aging Contributes to Failure of Cold-Induced Beige Adipocyte Formation in Old Mice and Humans
  84. Mesoderm, Cooked Up Fast and Served to Order
  85. Transcriptional Inhibitors Identified in a 160,000-Compound Small-Molecule DUX4 Viability Screen
  86. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
  87. Heterogeneity of Mesp1+ mesoderm revealed by single-cell RNA-seq
  88. High Frequency Hearing Loss and Hyperactivity in DUX4 Transgenic Mice
  89. DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes
  90. Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors
  91. Germ Cell Nuclear Factor (GCNF) Represses Oct4 Expression and Globally Modulates Gene Expression in Human Embryonic Stem (hES) Cells
  92. GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells
  93. Development of Bipotent Cardiac/Skeletal Myogenic Progenitors from MESP1+ Mesoderm
  94. Flow Cytometry and Transplantation-Based Quantitative Assays for Satellite Cell Self-Renewal and Differentiation
  95. Freeze Injury of the Tibialis Anterior Muscle
  96. DNA-binding sequence specificity of DUX4
  97. Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells
  98. Drosophila Cyclin G and epigenetic maintenance of gene expression during development
  99. Derivation and High Engraftment of Patient-Specific Cardiomyocyte Sheet Using Induced Pluripotent Stem Cells Generated From Adult Cardiac Fibroblast
  100. Acquisition of a Quantitative, Stoichiometrically Conserved Ratiometric Marker of Maturation Status in Stem Cell-Derived Cardiac Myocytes
  101. OVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells
  102. Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 Transgene
  103. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators
  104. Webber BR, Iacovino M, Choi SH, Tolar J, Kyba M, Blazar BR. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo. Blood. 2013;122(17):2978-2986.
  105. TBX3 Directs Cell-Fate Decision toward Mesendoderm
  106. Cooperative interaction of Etv2 and Gata2 regulates the development of endothelial and hematopoietic lineages
  107. Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons
  108. High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity
  109. Molecular Functions of the LIM-Homeobox Transcription Factor Lhx2 in Hematopoietic Progenitor Cells Derived from Mouse Embryonic Stem Cells
  110. Rapid Genetic Modification of Mouse Embryonic Stem Cells by Inducible Cassette Exchange Recombination
  111. NLRP7 affects trophoblast lineage differentiation, binds to overexpressed YY1 and alters CpG methylation
  112. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo
  113. TBX3 Directs Cell-Fate Decision toward Mesendoderm
  114. Expression of the Human FSHD-Linked DUX4 Gene Induces Neurogenesis During Differentiation of Murine Embryonic Stem Cells
  115. Expression levels of endoglin distinctively identify hematopoietic and endothelial progeny at different stages of yolk sac hematopoiesis
  116. Nkx2-5 Mediates Differential Cardiac Differentiation Through Interaction with Hoxa10
  117. A New Immuno-, Dystrophin-Deficient Model, theNSG-mdx4CvMouse, Provides Evidence for Functional Improvement Following Allogeneic Satellite Cell Transplantation
  118. Mesp1 Patterns Mesoderm into Cardiac, Hematopoietic, or Skeletal Myogenic Progenitors in a Context-Dependent Manner
  119. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
  120. Hemogenic endothelium in a dish
  121. A focal domain of extreme demethylation within D4Z4 in FSHD2
  122. BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets
  123. The Plasminogen Activation System Modulates Differently Adipogenesis and Myogenesis of Embryonic Stem Cells
  124. Generation of functional thyroid from embryonic stem cells
  125. Etv2 Is Expressed in the Yolk Sac Hematopoietic and Endothelial Progenitors and Regulates Lmo2 Gene Expression
  126. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r
  127. Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice
  128. A critical role for endoglin in the emergence of blood during embryonic development
  129. Eomesodermin induces Mesp1 expression and cardiac differentiation from embryonic stem cells in the absence of Activin
  130. p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
  131. Satellite cell heterogeneity revealed by G-Tool, an open algorithm to quantify myogenesis through colony-forming assays
  132. Zinc Finger Protein ZFP57 Requires Its Co-factor to Recruit DNA Methyltransferases and Maintains DNA Methylation Imprint in Embryonic Stem Cells via Its Transcriptional Repression Domain
  133. Embryonic stem cell–based mapping of developmental transcriptional programs
  134. ER71 directs mesodermal fate decisions during embryogenesis
  135. Inducible Cassette Exchange: A Rapid and Efficient System Enabling Conditional Gene Expression in Embryonic Stem and Primary Cells
  136. Characterization of an In Vitro Differentiation Assay for Pancreatic-Like Cell Development from Murine Embryonic Stem Cells: Detailed Gene Expression Analysis
  137. The Wnt3a/β-catenin target gene Mesogenin1 controls the segmentation clock by activating a Notch signalling program
  138. Modulation of TGF-  signaling by endoglin in murine hemangioblast development and primitive hematopoiesis
  139. Decreased Proliferation Kinetics of Mouse Myoblasts Overexpressing FRG1
  140. Snail and the microRNA-200 Family Act in Opposition to Regulate Epithelial-to-Mesenchymal Transition and Germ Layer Fate Restriction in Differentiating ESCs
  141. Assessment of the Myogenic Stem Cell Compartment Following Transplantation ofPax3/Pax7-Induced Embryonic Stem Cell-Derived Progenitors
  142. Nkx2-5 Represses Gata1 Gene Expression and Modulates the Cellular Fate of Cardiac Progenitors During Embryogenesis
  143. Functional Myogenic Engraftment from Mouse iPS Cells
  144. Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells
  145. Gene therapy by allele selection in a mouse model of beta-thalassemia
  146. Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cells
  147. An Inducible Expression System of the Calcium-Activated Potassium Channel 4 to Study the Differential Impact on Embryonic Stem Cells
  148. HoxA3 is an apical regulator of haemogenic endothelium
  149. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)
  150. Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene
  151. Proteomic Analysis of Sox2-Associated Proteins During Early Stages of Mouse Embryonic Stem Cell Differentiation Identifies Sox21 as a Novel Regulator of Stem Cell Fate
  152. The Retinoid Signaling Pathway Inhibits Hematopoiesis and Uncouples from the Hox Genes During Hematopoietic Development
  153. Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy
  154. Biphasic Myopathic Phenotype of Mouse DUX, an ORF within Conserved FSHD-Related Repeats
  155. Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery
  156. A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation
  157. A Conserved Role for Hox Paralog Group 4 in Regulation of Hematopoietic Progenitors
  158. Nkx2–5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo
  159. Mesodermal patterning activity of SCL
  160. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation
  161. White Fat Progenitor Cells Reside in the Adipose Vasculature
  162. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies
  163. Prospective Isolation of Skeletal Muscle Stem Cells with a Pax7 Reporter
  164. Mesp1 Coordinately Regulates Cardiovascular Fate Restriction and Epithelial-Mesenchymal Transition in Differentiating ESCs
  165. Mesp1 Acts as a Master Regulator of Multipotent Cardiovascular Progenitor Specification
  166. Caspase Activity Mediates the Differentiation of Embryonic Stem Cells
  167. ER71 Acts Downstream of BMP, Notch, and Wnt Signaling in Blood and Vessel Progenitor Specification
  168. An ES cell-derived immune system
  169. Functional skeletal muscle regeneration from differentiating embryonic stem cells
  170. GATA2 functions at multiple steps in hemangioblast development and differentiation
  171. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm
  172. Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factor
  173. Genesis of Hematopoietic Stem Cells In Vitro and In Vivo: New Insights into Developmental Maturation
  174. Nuclear transplantation, embryonic stem cells and the potential for cell therapy
  175. Hematopoiesis from embryonic stem cells: lessons from and for ontogeny
  176. Hematopoiesis from embryonic stem cells: lessons from and for ontogeny
  177. Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5
  178. A Role for Thrombopoietin in Hemangioblast Development
  179. Development of Hematopoietic Repopulating Cells from Embryonic Stem Cells
  180. HoxB4 Confers Definitive Lymphoid-Myeloid Engraftment Potential on Embryonic Stem Cell and Yolk Sac Hematopoietic Progenitors
  181. Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems
  182. Correction of a Genetic Defect by Nuclear Transplantation and Combined Cell and Gene Therapy
  183. Tantalus, a Novel ASX-Interacting Protein with Tissue-Specific Functions
  184. A novel member of murine Polycomb-group proteins, Sex comb on midleg homolog protein, is highly conserved, and interacts with RAE28/mph1 in vitro
  185. The Drosophila Polycomb Group Protein Psc Contacts ph and Pc through Specific Conserved Domains
  186. RAE28, BMI1, and M33 Are Members of Heterogeneous Multimeric Mammalian Polycomb Group Complexes
  187. The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes
  188. The SAM domain of polyhomeotic, RAE28, and Scm mediates specific interactions through conserved residues
  189. A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions.
  190. The polyhomeotic locus of Drosophila melanogaster is transcriptionally and post-transcriptionally regulated during embryogenesis